FDA warning letter · Drugs

Alternative Health Distribution LLC d/b/a CannaAid

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352.

Passage 2

In addition, it is unlawful under the FTC Act, 15 U.S.C. § 41 et seq., to advertise that a product can prevent, treat, or cure human disease unless you possess competent and reliable scientific evidence, including, when appropriate, well-controlled human clinical studies, substantiating that the claims are true at the time they are made.